OsteoPhilicity

PEEK spinal implants with improved bone in-growth capability.

  • Stage Product In Development
  • Industry Biotechnology
  • Location San Francisco, CA, USA
  • Currency USD
  • Founded May 2018
  • Employees 2
  • Incorporation Type LLC
  • Website http://-

Company Summary

Over 65 million adults in the US suffer from chronic back pain. 1 million of them will undergo spinal fusion surgery. 10% of these patients will need revision because of implant failure. At over $100,000 per surgery, failed implants cause a $10 billion burden on our healthcare system every year. We are on a mission to stop this from happening. Our patented technology processes existing spinal implants to help them perform better and not fail.

Team

  • 2x entrepreneur, strong proponent of lean-startup practices.
    3 years of experience in medical device innovation, healthcare market research, identifying product-market fit, and GTM strategy.
    10+ years of experience in product development, design for regulatory conformance. Successfully led development (from ideation to launch) of hardware/software products in aviation, satellite, telecom, 4k-2k video streaming, ed-tech, and mHealth industries.

  • Dr. Saadyah Averick
    Chief Scientist

    Over 64 peer-reviewed publications in the field of novel biomaterials, polymer hybrids, coatings for medical devices. Inventor of numerous patents, including Aqua-PEEK's underlying science, and the lead scientist at the Allegheny-Singer Research Institute's neuroscience research lab.

Advisors

  • Dr. Boyle Cheng
    Unconfirmed
    Dr. Keith Lejeune
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free